Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

Abroad (travel likely)RecruitingPHASE3

Conditions

Long COVID · Sars-CoV-2 Infection · Coronavirus Infections · COVID-19

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Arizona, Tucson, Arizona, United States
Contact: Study coordinator (Sairam Parthasarathy, MD) · spartha1@arizona.edu · (520) 626-8309
Contact: Study coordinator (Arianna Bedoya, MPH) · aresendiz@arizona.edu · (520) 626-1590
University of California, Los Angeles (UCLA), Los Angeles, California, United States
Contact: Study coordinator (Priscilla Y Hsue, MD) · phsue@mednet.ucla.edu
Contact: Study coordinator (Veronica L Schaffer) · vschaffer@mednet.ucla.edu
University of California San Francisco, San Francisco, California, United States
Contact: Study coordinator (Michael Peluso, MD) · Michael.Peluso@ucsf.edu · (617) 910-0584
University of Colorado I Anschutz Medical Campus, Aurora, Colorado, United States
Contact: Study coordinator (Sarah Jolley, MD) · sarah.jolley@cuanschutz.edu · (303) 724-2902
Contact: Study coordinator (Jeff McKeehan, MSN, AC-AGNP) · jeffrey.mckeehan@cuanschutz.edu · (303) 724-6080
Yale University, New Haven, Connecticut, United States
Contact: Study coordinator (Basmah Safdar, MD) · rvlcyale@yale.edu · (475) 306-5688
Contact: Study coordinator (Anirudh Goyal, MPH) · anirudh.goyal@yale.edu
University of Florida College of Medicine, Gainesville, Florida, United States
Contact: Study coordinator (Nicole Iovine, MD, PhD) · nicole.iovine@medicine.ufl.edu · (352) 273-5481
Contact: Study coordinator (Alexandra Taylor, MS) · tayloralexandra@ufl.edu · (352) 294-4248
Emory University, Atlanta, Georgia, United States
Contact: Study coordinator (Vincent Marconi, MD) · vcmarco@emory.edu · (404) 727-2343
Illinois Research Network (ILLInet), University of Illinois Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Jerry A Krishnan, MD, PhD) · jakris@uic.edu · (410) 960-1694
Contact: Study coordinator (Andrea Wendrow, RPh) · awendrow@uic.edu · (312) 413-9588
Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Lindsey R Baden, MD) · vaccines@partners.org · 6175257327
University of Minnesota, Minneapolis, Minnesota, United States
Contact: Study coordinator (Carolyn Bramante, MD, MPH) · bramante@umn.edu · (651) 717-8915
NYU Langone Health - Brooklyn, Brooklyn, New York, United States
Contact: Study coordinator (Jennifer Frontera, MD) · Jennifer.Frontera@nyulangone.org · (718) 630-6689
Contact: Study coordinator (Zariya Alvarez, MPH) · zariya.alvarez@nyulangone.org · (917) 613-5770
University Hospitals Cleveland Case Western, Cleveland, Ohio, United States
Contact: Study coordinator (Grace McComsey, MD) · (216) 368-3731
Contact: Study coordinator (Danielle Labbato, BSN, RN) · Danielle.Labbato@uhhospitals.org · (216) 844-2739
The MetroHealth System, Cleveland, Ohio, United States
Contact: Study coordinator (Nora Singer, MD) · nsinger@metrohealth.org · (216) 778-3693
Contact: Study coordinator (Emma Barnboym, BSNs) · ebarnboym@metroHealth.org · (216) 778-3752
Vanderbilt University Medical, Nashville, Tennessee, United States
Contact: Study coordinator (Matthew Mart, MD, MSCI) · matthew.f.mart@vumc.org · (615) 322-0184
University of Texas at San Antonio, San Antonio, Texas, United States
Contact: Study coordinator (Thmas F Patterson, MD) · patterson@uthscsa.edu · (210) 567-4810
Contact: Study coordinator (Barbara S Taylor, MD) · taylorBS4@uthscsa.edu · (210) 567-4823
Swedish Medical Center, Seattle, Washington, United States
Contact: Study coordinator (Jason Goldman, MD, MPH) · jason.goldman@swedish.org · (206) 386-3660
Contact: Study coordinator (Allie Duven, BSN) · RDResearch@providence.org · (206) 337-3864
West Virginia Clinical and Translational Science Institute, Morgantown, West Virginia, United States
Contact: Study coordinator (Madison Heltzel (nee Kelley), RN, BSN) · macey.kelley@hsc.wvu.edu · (304) 293-6360
Contact: Study coordinator (Tara Riddle, BA, MSW) · tlr0011@hsc.wvu.edu · (304) 581-1829
Contact: Principal Investigator (Sally Hodder, MD)

Study leads

Wes Ely, M.D.
Principal Investigator
Vanderbilt University Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Taurine Supplementation in Long COVID

Long COVID

Abroad (travel likely)RecruitingPHASE2, PHASE3

Edmonton, Canada · Vancouver, Canada

Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)

Smell Dysfunction · Olfactory Disorder · Long COVID

Abroad (travel likely)RecruitingPHASE2, PHASE3

Charleston, United States

Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19

Long COVID-19 Syndrome · COVID 19 · Noncommunicable Disease

Abroad (travel likely)Recruiting

Bogotá, Colombia

Long COVID Brain Fog: Cognitive Rehabilitation Trial

Long COVID · Brain Fog · Cognitive Impairment

Abroad (travel likely)Recruiting

Birmingham, United States